Specialty insurance provider Skyward Specialty Insurance (NASDAQ: SKWD) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 53% year on year to $489.5 million. Its non-GAAP profit of $1.30 per share was 10.8% above analysts’ consensus estimates.
Is now the time to buy Skyward Specialty Insurance? Find out by accessing our full research report, it’s free.
Skyward Specialty Insurance (SKWD) Q2 CY2026 Highlights:
- Net Premiums Earned: $444.5 million vs analyst estimates of $429.7 million (50.4% year-on-year growth, 3.4% beat)
- Revenue: $489.5 million vs analyst estimates of $468.9 million (53% year-on-year growth, 4.4% beat)
- Combined Ratio: 89.5% vs analyst estimates of 90.4% (92.5 basis point beat)
- Adjusted EPS: $1.30 vs analyst estimates of $1.17 (10.8% beat)
- Book Value per Share: $28.55 vs analyst estimates of $28.00 (28.4% year-on-year growth, 2% beat)
- Market Capitalization: $2.47 billion
Company Overview
Founded in 2006 to serve markets where standard insurance coverage falls short, Skyward Specialty Insurance (NASDAQ: SKWD) provides customized commercial property, casualty, and health insurance solutions for underserved or specialized market niches.
Revenue Growth
Insurance companies earn revenue from three primary sources: 1) The core insurance business itself, often called underwriting and represented in the income statement as premiums 2) Income from investing the “float” (premiums collected upfront not yet paid out as claims) in assets such as fixed-income assets and equities 3) Fees from various sources such as policy administration, annuities, or other value-added services. Thankfully, Skyward Specialty Insurance’s 29.5% annualized revenue growth over the last five years was incredible. Its growth surpassed the average insurance company and shows its offerings resonate with customers, a great starting point for our analysis.
We at StockStory place the most emphasis on long-term growth, but within financials, a half-decade historical view may miss recent interest rate changes, market returns, and industry trends. Skyward Specialty Insurance’s annualized revenue growth of 29.7% over the last two years aligns with its five-year trend, suggesting its demand was predictably strong. 
Note: Quarters not shown were determined to be outliers because they were impacted by outsized investment gains/losses that are not indicative of the recurring fundamentals of the business.
This quarter, Skyward Specialty Insurance reported magnificent year-on-year revenue growth of 53%, and its $489.5 million of revenue beat Wall Street’s estimates by 4.4%.
Net premiums earned made up 92.6% of the company’s total revenue during the last five years, meaning Skyward Specialty Insurance lives and dies by its underwriting activities because non-insurance operations barely move the needle.
Net premiums earned command greater market attention due to their reliability and consistency, whereas investment and fee income are often seen as more volatile revenue streams that fluctuate with market conditions.
ALSO WORTH WATCHING: Nvidia’s Quiet Partner. Nvidia’s chips cost a hundred grand. The connectors that make them work cost even more. One company makes them all.
Every AI server needs specialized infrastructure the chip companies don’t make. High-speed cables. Power connectors. Thermal sensors. This 90-year-old company built a monopoly on it. The AI boom just started. This stock is still flying under the radar. Claim The Stock Ticker Here for FREE.
Book Value Per Share (BVPS)
Insurance companies are balance sheet businesses, collecting premiums upfront and paying out claims over time. The float — premiums collected but not yet paid out — is invested, creating an asset base supported by a liability structure. Book value captures this dynamic by measuring:
- Assets (investment portfolio, cash, reinsurance recoverables) - liabilities (claim reserves, debt, future policy benefits)
BVPS is essentially the residual value for shareholders.
We therefore consider BVPS very important to track for insurers and a metric that sheds light on business quality because it reflects long-term capital growth and is harder to manipulate than more commonly-used metrics like EPS.
Skyward Specialty Insurance’s BVPS grew at a sluggish 3% annual clip over the last four years. However, BVPS growth has accelerated recently, growing by 25.8% annually over the last two years from $18.05 to $28.55 per share.
Over the next 12 months, Consensus estimates call for Skyward Specialty Insurance’s BVPS to grow by 14.2% to $28.00, top-notch growth rate.
Key Takeaways from Skyward Specialty Insurance’s Q2 Results
We were impressed by how significantly Skyward Specialty Insurance blew past analysts’ net premiums earned expectations this quarter. We were also excited its revenue outperformed Wall Street’s estimates by a wide margin. Zooming out, we think this quarter featured some important positives. Investors were likely hoping for more, and shares traded down 2.7% to $59.86 immediately after reporting.
Big picture, is Skyward Specialty Insurance a buy here and now? We think that the latest quarter is only one piece of the longer-term business quality puzzle. Quality, when combined with valuation, can help determine if the stock is a buy. We cover that in our actionable full research report which you can read here (it’s free).
